PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 69 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $3,000 | -66.7% | 399 | -67.0% | 0.00% | -100.0% |
| Q4 2019 | $9,000 | -78.0% | 1,210 | -64.9% | 0.00% | -66.7% |
| Q3 2019 | $41,000 | +1266.7% | 3,450 | +1433.3% | 0.00% | – |
| Q2 2019 | $3,000 | -62.5% | 225 | -65.1% | 0.00% | -100.0% |
| Q1 2019 | $8,000 | +33.3% | 644 | -29.8% | 0.00% | 0.0% |
| Q4 2018 | $6,000 | -25.0% | 917 | +13.9% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | -99.6% | 805 | +203.8% | 0.00% | – |
| Q2 2018 | $1,781,000 | +88950.0% | 265 | -22.7% | 0.00% | – |
| Q1 2018 | $2,000 | -75.0% | 343 | -14.5% | 0.00% | -100.0% |
| Q4 2017 | $8,000 | +700.0% | 401 | +407.6% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 79 | +46.3% | 0.00% | – |
| Q1 2017 | $1,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $19,373,000 | 4.95% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $17,881,000 | 2.10% |
| Finepoint Capital LP | 735,126 | $5,815,000 | 2.01% |
| Altium Capital Management LP | 365,100 | $2,888,000 | 1.16% |
| RTW INVESTMENTS, LP | 4,794,499 | $37,924,000 | 0.98% |
| Amitell Capital Pte Ltd | 50,129 | $397,000 | 0.90% |
| COWEN AND COMPANY, LLC | 1,065,724 | $8,430,000 | 0.81% |
| Tri Locum Partners LP | 155,000 | $1,226,000 | 0.50% |
| BVF INC/IL | 1,106,838 | $8,755,000 | 0.42% |
| HighVista Strategies LLC | 46,459 | $367,000 | 0.22% |